BioBiggen
- Headquarters
- Beijing
- Business Model
- B2B
- Website
- biobiggen.com
- Last Round
- Venture RoundMay 2021
- Rounds
- 2
About
BioBiggen (Beijing Bohao Yuntian Technology Co., Ltd.) is a technology innovation enterprise co-founded by a senior management team with deep experience in the non-invasive prenatal testing market together with a team of internationally renowned medical geneticists, backed by several top-tier venture capital investors. The company positions itself as a global leader in non-invasive prenatal simultaneous screening technology for chromosomal and monogenic diseases, guided by a mission of serving public health.
Summary
BioBiggen is a Biotech company based in Beijing, China. Its most recent funding was a Venture Round round in May 2021. Investors include Eight Roads Ventures, LAV (Lilly Asia Ventures) and Lapam Capital.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...